miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate platinum resistance and is a suitable serum biomarker for oxaliplatin resistance.
In conclusion, miR-15a-5p was recognized as a biomarker for platinum resistance and prognosis in gastric cancer, interference of which may be a promising strategy for sensitizing gastric cancer to platinum drugs.
PMID: 32567934 [PubMed - as supplied by publisher]
Source: Neoplasma - Category: Cancer & Oncology Authors: Pang K, Song J, Bai Z, Zhang Z Tags: Neoplasma Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Study